STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

GSK GSK PUBLIC LIMITED COMPANY StockScouter® Report

7

StockScouter® Score

GSK PUBLIC LIMITED COMPANY, a large cap growth company in the healthcare sector, is expected to outperform the market over the next six months with less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The most recent quarterly earnings report higher than analysts’ consensus forecast. Positive
  • The enterprise value-to-sales ratio is lower than the average for comparably-sized companies in the StockScouter universe. Positive

 

Concerns

  • Earnings growth in the past year has decelerated moderately compared to earnings growth in the past three years. Negative
  • The ratio of GSK’s forward price-to-earnings multiple to its estimated growth rate is above the average of comparably-sized companies in the StockScouter universe. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that large cap stocks will be neutral, growth stocks will be in favor, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 20% done.
Progress: 100% done.
Low
High

Core Model Grades

C
C
B
B

Previous Ratings

7
5
6